Literature DB >> 11023468

Antigenic conservation of an immunodominant invariable region of the VlsE lipoprotein among European pathogenic genospecies of Borrelia burgdorferi SL.

F T Liang1, E Aberer, M Cinco, L Gern, C M Hu, Y N Lobet, M Ruscio, P E Voet, V E Weynants, M T Philipp.   

Abstract

Lyme disease is caused by genetically divergent spirochetes, including 3 pathogenic genospecies: Borrelia burgdorferi sensu stricto, B. garinii, and B. afzelii. Serodiagnosis is complicated by this genetic diversity. A synthetic peptide (C(6)), based on the 26-mer invariable region (IR(6)) of the variable surface antigen of B. burgdorferi (VlsE), was used as ELISA antigen, to test serum samples collected from mice experimentally infected with the 3 genospecies and from European patients with Lyme disease. Regardless of the infecting strains, mice produced a strong antibody response to C(6), which indicates that IR(6) is antigenically conserved among the pathogenic genospecies. Twenty of 23 patients with culture-confirmed erythema migrans had a detectable antibody response to C(6). A sensitivity of 95.2% was achieved, with serum samples collected from patients with well-defined acrodermatitis chronica atrophicans. Fourteen of 20 patients with symptoms of late Lyme disease also had a positive anti-IR(6) ELISA. Thus, it is possible that C(6) may be used to serodiagnose Lyme disease universally.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11023468     DOI: 10.1086/315862

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  37 in total

1.  Evaluation of the C6 peptide enzyme-linked immunosorbent assay for individuals vaccinated with the recombinant OspA vaccine.

Authors:  Adriana R Marques; Dale S Martin; Mario T Philipp
Journal:  J Clin Microbiol       Date:  2002-07       Impact factor: 5.948

2.  A decline in C6 antibody titer occurs in successfully treated patients with culture-confirmed early localized or early disseminated Lyme Borreliosis.

Authors:  Mario T Philipp; Gary P Wormser; Adriana R Marques; Susan Bittker; Dale S Martin; John Nowakowski; Leonard G Dally
Journal:  Clin Diagn Lab Immunol       Date:  2005-09

3.  Tick-borne Diseases (Borreliosis, Anaplasmosis, Babesiosis) in German and Austrian Dogs: Status quo and Review of Distribution, Transmission, Clinical Findings, Diagnostics and Prophylaxis.

Authors:  Nikola Pantchev; Silvia Pluta; Elke Huisinga; Stephanie Nather; Miriam Scheufelen; Majda Globokar Vrhovec; Andrea Schweinitz; Herwig Hampel; Reinhard K Straubinger
Journal:  Parasitol Res       Date:  2015-08       Impact factor: 2.289

Review 4.  Microbial antigenic variation mediated by homologous DNA recombination.

Authors:  Cornelis Vink; Gloria Rudenko; H Steven Seifert
Journal:  FEMS Microbiol Rev       Date:  2012-01-17       Impact factor: 16.408

5.  Significant improvement of the recombinant Borrelia-specific immunoglobulin G immunoblot test by addition of VlsE and a DbpA homologue derived from Borrelia garinii for diagnosis of early neuroborreliosis.

Authors:  Ulrike Schulte-Spechtel; Gisela Lehnert; Gaby Liegl; Volker Fingerle; Christiane Heimerl; Barbara J B Johnson; Bettina Wilske
Journal:  J Clin Microbiol       Date:  2003-03       Impact factor: 5.948

6.  BBK07, a dominant in vivo antigen of Borrelia burgdorferi, is a potential marker for serodiagnosis of Lyme disease.

Authors:  Adam S Coleman; Utpal Pal
Journal:  Clin Vaccine Immunol       Date:  2009-09-23

7.  Pre-treatment and post-treatment assessment of the C(6) test in patients with persistent symptoms and a history of Lyme borreliosis.

Authors:  R V Fleming; A R Marques; M S Klempner; C H Schmid; L G Dally; D S Martin; M T Philipp
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2004-07-08       Impact factor: 3.267

8.  Genetic variation at the vlsE locus of Borrelia burgdorferi within ticks and mice over the course of a single transmission cycle.

Authors:  Jun Ohnishi; Brad Schneider; William B Messer; Joseph Piesman; Aravinda M de Silva
Journal:  J Bacteriol       Date:  2003-08       Impact factor: 3.490

9.  Comparison of Western immunoblotting and the C6 Lyme antibody test for laboratory detection of Lyme disease.

Authors:  Elena Mogilyansky; Chien Chang Loa; Martin E Adelson; Eli Mordechai; Richard C Tilton
Journal:  Clin Diagn Lab Immunol       Date:  2004-09

10.  Dogs vaccinated with common Lyme disease vaccines do not respond to IR6, the conserved immunodominant region of the VlsE surface protein of Borrelia burgdorferi.

Authors:  Thomas P O'Connor; Kathy J Esty; Jancy L Hanscom; Paulette Shields; Mario T Philipp
Journal:  Clin Diagn Lab Immunol       Date:  2004-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.